Quebec SEAO #20175646

CGH microarrays and laboratory supplies for Santé Québec’s genomic hybridization platform

Santé Québec is seeking genomic hybridization microarrays and related laboratory supplies for CHU de Québec - Université Laval’s established platform. - Buyer: Santé Québec, through CHU de Québec - Université Laval. - Intended supplier and OEM: Revvity Health Sciences Canada, inc. The notice names Revvity as the intended supplier; no actual order quantities are specified. - Products requested: - CGX-HD 4plex CGH microarray (GRM 793249). - 4plex microarray hybridization kit, capacity for 100 patients (GRM 793250). - 4plex microarray DNA labeling kit, capacity for 25 patients (GRM 793251). - CGX Oligo aCGH 4plex microarray wash solutions, capacity for 160 patients (GRM 793260). - Human Cot-1 DNA for 4plex microarray, capacity for 125 patients (GRM 793261). - CGX HD/SNP-100 microarray sealing gasket (GRM 793262). - Key technical requirements: The non-SNP CGH arrays must use a 4x180k format and validated human oligonucleotide design. Products must work with the existing Agilent SureScan scanner and Genoglyphix software without adaptations, provide the required genome-wide and clinically significant region resolution, and support detection of more than 200 microdeletion/microduplication regions and over 900 clinically relevant genes. - Analysis and support requirements: Secure remote analysis with activity traceability, automated reporting, and integration with ClinVar, DGV, Decipher, and OMIM. Delivery must provide at least six months of remaining shelf life; frozen products must ship on dry ice. The notice also requires delivery within six weeks, responsive technical support, documentation, ongoing training, and guaranteed Canadian buffer stock. - Procurement rationale and notice outcome: The buyer cites continuity with its established platform and database, traceability, validation, operational risks, and transition risks. The notice invites qualified companies to express interest; a legally admissible, qualified response would lead to a public tender.

Description

Santé Québec - CHU de Québec - Université Laval is seeking kits and microarrays for its genomic hybridization platform through an intention to enter into a negotiated contract without public tender. The products include CGH microarrays and related hybridization, DNA labeling, washing-solution, Cot-1 DNA, and sealing-gasket supplies. Requirements include compatibility with the Agilent SureScan scanner and Genoglyphix software, specified analytical resolution and detection capabilities, secure remote analysis, reporting and database interoperability, delivery and shelf-life conditions, and supplier support and Canadian inventory. Expressions of interest are due electronically by October 23, 2026; if a qualified, legally admissible expression is received, the organization says it will proceed with a public tender.

View original listing